Constitutive AMPK activation prevents hepatocellular carcinoma development through inhibition of HNF4α activity
Science Advances · 2026-04-10 · 12 (15)
DOI: 10.1126/sciadv.aea8017 ↗At a glance
Journal article in Science Advances, published on 2026-04-10. Written by Zhen Sun and 6 co-authors. Institution: Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, TX 77030, USA. Major MEDLINE topics: Hepatocyte Nuclear Factor 4, AMP-Activated Protein Kinases, Carcinoma, Hepatocellular, Liver Neoplasms. 132 references. The full text is freely available in PubMed Central. Funded by: NCI NIH HHS, NIGMS NIH HHS, National Institutes of Health.
Abstract (original language)
Hepatocellular carcinoma (HCC) is a major cause of cancer-related mortality and is largely driven by metabolic disorders such as obesity and type 2 diabetes. The AMP-activated protein kinase (AMPK) is a master regulator of metabolism, and its activation has been proposed as a therapeutic strategy for treating metabolic disorders. However, although AMPK activity is down-regulated in HCC, the precise role of AMPK in HCC development has not been clearly delineated. Here, we investigated the ability of constitutive AMPK activation to prevent HCC development using a constitutively active AMPK transgenic mouse model and a pharmacological AMPK activator. We observed that AMPK activation substantially reduced tumor formation in both diethylnitrosamine (DEN)–induced and streptozocin-induced (STAM) models of HCC via altered bile acid metabolism and inhibition of hepatic nuclear factor alpha (HNF4α) signaling. These findings provide mechanistic insights into AMPK biology and highlight the potential of AMPK as a therapeutic target, emphasizing the intricate interplay between metabolic dysregulation and cancer development.
Subjects
MeSH terms (MEDLINE)
Substances
Authors and institutions
- Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, TX 77030, USA.
- Dan L Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, TX 77030, USA.
- Advanced Technology Core, Dan L. Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, TX 77030, USA.
ORCID profiles: Zhen Sun, Bernard Linares, Nagireddy Putluri, Jeanine L Van Nostrand
Funding
- NCI NIH HHS
- NIGMS NIH HHS
- National Institutes of Health
- National Institute of Diabetes and Digestive and Kidney Diseases
- Cancer Prevention and Research Institute of Texas
- Dan L. Duncan Cancer Center, Baylor College of Medicine
Cite
APA
Sun, Z., Linares, B., Urdiales, C., Alsarmi, F., Sang, B., Putluri, N., & Van Nostrand, J. L. (2026). Constitutive AMPK activation prevents hepatocellular carcinoma development through inhibition of HNF4α activity. Science Advances, 12(15). https://doi.org/10.1126/sciadv.aea8017
Vancouver
Sun Z, Linares B, Urdiales C, Alsarmi F, Sang B, Putluri N, et al. Constitutive AMPK activation prevents hepatocellular carcinoma development through inhibition of HNF4α activity. Science Advances. 2026;12(15). doi:10.1126/sciadv.aea8017
BibTeX
@article{Sun2026,
author = {Sun, Zhen and Linares, Bernard and Urdiales, Cassidy and Alsarmi, Fiyad and Sang, Boyuan and Putluri, Nagireddy and Van Nostrand, Jeanine L},
title = {Constitutive AMPK activation prevents hepatocellular carcinoma development through inhibition of HNF4α activity},
journal = {Science Advances},
year = {2026},
volume = {12},
number = {15},
doi = {10.1126/sciadv.aea8017}
}
EUVIMED